Erste Asset Management Gmb H Morphic Holding, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.35 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 26, 2024
BUY
$22.23 - $33.37 $188,955 - $283,645
8,500 New
8,500 $238 Million
Q2 2022

Nov 26, 2024
BUY
$19.74 - $43.01 $167,790 - $365,585
8,500 New
8,500 $180 Million
Q1 2022

Nov 22, 2024
BUY
$36.25 - $52.02 $308,125 - $442,170
8,500 New
8,500 $343 Million

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email